Alligator Bioscience’s Annual Report 2017 published
Lund, Sweden, 22 March – Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, announced today that the Annual Report 2017 is available at the company website www.alligatorbioscience.com . For further information, please contact:Cecilia Hofvander, Director Investor Relations & CommunicationsPhone +46 46 286 44 95E-mail: cecilia.hofvander@alligatorbioscience.com. This information is such information as Alligator Bioscience AB (publ) is obliged to